CS182300B2 - Process for preparing 1,3-oxidated 8alfa-estratrienes - Google Patents

Process for preparing 1,3-oxidated 8alfa-estratrienes

Info

Publication number
CS182300B2
CS182300B2 CS7600001694A CS169476A CS182300B2 CS 182300 B2 CS182300 B2 CS 182300B2 CS 7600001694 A CS7600001694 A CS 7600001694A CS 169476 A CS169476 A CS 169476A CS 182300 B2 CS182300 B2 CS 182300B2
Authority
CS
Czechoslovakia
Prior art keywords
8alfa
estratrienes
oxidated
preparing
oxidated 8alfa
Prior art date
Application number
CS7600001694A
Other languages
Czech (cs)
English (en)
Inventor
Klaus Prezewowsky
Henry Laurent
Helmut Hofmeister
Rudolf Wiechert
Friedmund Neumann
Yukishige Nishino
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2336431A external-priority patent/DE2336431C2/de
Priority claimed from DE19742426777 external-priority patent/DE2426777A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of CS182300B2 publication Critical patent/CS182300B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
CS7600001694A 1973-07-13 1974-07-12 Process for preparing 1,3-oxidated 8alfa-estratrienes CS182300B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2336431A DE2336431C2 (de) 1973-07-13 1973-07-13 1.3-oxygenierte 8 alpha-Östratriene, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19742426777 DE2426777A1 (de) 1974-05-31 1974-05-31 1.3-oxygenierte 8 alpha-oestratriene

Publications (1)

Publication Number Publication Date
CS182300B2 true CS182300B2 (en) 1978-04-28

Family

ID=25765510

Family Applications (2)

Application Number Title Priority Date Filing Date
CS7600001694A CS182300B2 (en) 1973-07-13 1974-07-12 Process for preparing 1,3-oxidated 8alfa-estratrienes
CS7400004984A CS182260B2 (en) 1973-07-13 1974-07-12 Method of producing 1,3-oxidated 8alfa-estratrienes

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS7400004984A CS182260B2 (en) 1973-07-13 1974-07-12 Method of producing 1,3-oxidated 8alfa-estratrienes

Country Status (18)

Country Link
JP (1) JPS5821639B2 (enrdf_load_stackoverflow)
AT (1) ATA575574A (enrdf_load_stackoverflow)
AU (1) AU477010B2 (enrdf_load_stackoverflow)
CA (1) CA1030951A (enrdf_load_stackoverflow)
CH (2) CH614217A5 (enrdf_load_stackoverflow)
CS (2) CS182300B2 (enrdf_load_stackoverflow)
DD (1) DD114066A5 (enrdf_load_stackoverflow)
DK (1) DK133051C (enrdf_load_stackoverflow)
ES (1) ES428226A1 (enrdf_load_stackoverflow)
FI (1) FI54131C (enrdf_load_stackoverflow)
FR (1) FR2236505B1 (enrdf_load_stackoverflow)
GB (1) GB1479934A (enrdf_load_stackoverflow)
HU (1) HU169791B (enrdf_load_stackoverflow)
IE (1) IE39872B1 (enrdf_load_stackoverflow)
IL (1) IL45259A (enrdf_load_stackoverflow)
NO (1) NO742546L (enrdf_load_stackoverflow)
SE (1) SE7409151L (enrdf_load_stackoverflow)
SU (1) SU626705A3 (enrdf_load_stackoverflow)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2551214C2 (de) * 1975-11-12 1984-07-12 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 1,3-oxygenierten 8α-Östratrienen
JPS5862734U (ja) * 1981-10-22 1983-04-27 日工株式会社 型枠支持サボ−ト
JPS59146759A (ja) * 1984-01-06 1984-08-22 株式会社日立製作所 自動ねじ込み装置
JPS60155376A (ja) * 1984-01-24 1985-08-15 松下電器産業株式会社 ナツト浮き検出装置
DE3710728A1 (de) * 1987-03-31 1988-10-13 Schering Ag Verfahren zur herstellung von 17(alpha)-ethinyl-17ss-hydroxy-18-methyl-4,15-estradien-3-on und die neuen zwischenprodukte fuer dieses verfahren
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US6903084B2 (en) 1991-08-28 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
RU2679625C1 (ru) * 2018-11-08 2019-02-12 Ильясов Шамиль Сионович ПРИМЕНЕНИЕ 3-О-СУЛЬФАМОИЛОКСИ-6-ОКСА-7β-МЕТИЛ-D-ГОМО-8α-ЭСТРА-1,3,5(10)-ТРИЕН-17а-ОНА ДЛЯ ЛЕЧЕНИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ, ВКЛЮЧАЯ ТРИЖДЫ-НЕГАТИВНУЮ ФОРМУ, И СПОСОБ ЕГО ПОЛУЧЕНИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3436411A (en) * 1967-12-28 1969-04-01 American Home Prod Process for cleaving an a-ring ether group in 13-alkylgona (and 8-isogona)-1,3,5(10)-trienes and delta-7-,delta-8(9)-,and delta-8(9),14(15)-dehydro derivatives thereof

Also Published As

Publication number Publication date
AU477010B2 (en) 1976-10-14
DK133051C (da) 1976-08-16
GB1479934A (en) 1977-07-13
CA1030951A (en) 1978-05-09
CH609064A5 (en) 1979-02-15
FI54131C (fi) 1978-10-10
DK368074A (enrdf_load_stackoverflow) 1975-03-17
JPS5821639B2 (ja) 1983-05-02
JPS5032160A (enrdf_load_stackoverflow) 1975-03-28
SU626705A3 (ru) 1978-09-30
IE39872L (en) 1975-01-13
FR2236505B1 (enrdf_load_stackoverflow) 1977-07-08
DK133051B (da) 1976-03-15
SE7409151L (sv) 1975-01-14
FI54131B (fi) 1978-06-30
HU169791B (en) 1977-01-28
CS182260B2 (en) 1978-04-28
FR2236505A1 (enrdf_load_stackoverflow) 1975-02-07
DD114066A5 (enrdf_load_stackoverflow) 1975-07-12
IL45259A0 (en) 1974-10-22
ATA575574A (de) 1978-05-15
IE39872B1 (en) 1979-01-17
ES428226A1 (es) 1976-07-16
CH614217A5 (en) 1979-11-15
FI213974A7 (enrdf_load_stackoverflow) 1975-01-14
AU7112374A (en) 1976-01-15
IL45259A (en) 1977-10-31
NO742546L (enrdf_load_stackoverflow) 1975-02-10

Similar Documents

Publication Publication Date Title
YU39603B (en) Process for preparing triazolyl-o,n-acetals
YU282474A (en) Process for obtaining 1,2-benzisooxazole derivatives
YU235174A (en) Process for preparing dodeca-7,9-diene-1-yl-acetate
CA1022191A (en) Process for preparing 2,6-dimethylnaphthalenes
ZA743234B (en) Process for preparing 3,4-dihydro-1,2,3-oxathiazine-4-ones
CA1019334A (en) Process for preparing 2,4-dimethyl-3-carboxanilido-or carboxanaphthylamido-furan
CS183763B2 (en) Process for preparing d-homosteroides
CS182300B2 (en) Process for preparing 1,3-oxidated 8alfa-estratrienes
YU39722B (en) Process for obtaining 0,0-diethyldithio-phoshoryl-methyl-3-chloro-6-benzoxazolone
YU217874A (en) Process for obtaining new 2,4-diaminobenzyl-pyrimidines
YU45274A (en) Process for preparing new substituted 2-phenylamino-imidazoline-(2)
CA1030541A (en) Process for preparing 4,5-diphenyl-oxazol-2-one
YU177974A (en) Process for preparing 2-carbalkoxy-amino-benzimidazole-5(6)-phenylethers
HU171222B (hu) Sposob poluchenija zamehhjonnykh 2,1,3-benzotiadiazin-4-on-2,2-dvuokisej
YU206774A (en) Process for obtaining 3,4-diamino-benzophenones
YU341974A (en) Process for preparing 4-amino-1,2,4-triazine-5-ones
CS183759B2 (en) Process for preparing acylaminophenylacetamidines
HU172290B (hu) Sposob poluchenija zamehhjonnogo 7h-indolizino/5,6,7-ij/ izokhinolina
HU171180B (hu) Sposob poluchenija 4,5-seko-steroidov
YU178074A (en) Process for preparing 2-carbalkoxy-amino-benzimidazole-5(6)-phenylethers
HU170762B (hu) Sposob poluchenija proizvodnykh 2,6-dinitro-anilina
CS182269B2 (en) Process for preparing alkylnaphtalenes
KR780000654B1 (en) Process for preparing 11,12-secoprostaglandins
CS189820B1 (en) Process for preparing 2,5-dichlor-1,4-phenylendiamine
HU172933B (hu) Sposob poluchenija ehfirov tipa 3,4-digidro-1-benzoksepin-5-on-oksima